Chlortetracycline

This MedLibrary.org supplementary page on Chlortetracycline is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Chlortetracycline
Systematic (IUPAC) name
(2Z,4S,4aS,5aS,6S,12aS)-2-(amino-hydroxy-
methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-
tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-
1,3,12-trione
Identifiers
CAS number 57-62-5
ATC code D06AA02 A01AB21
PubChem 5280963
Chemical data
Formula C22H23ClN2O8 
Mol. mass 478.879 g/mol
Pharmacokinetic data
Bioavailability 30%
Protein binding 50 to 55%
Metabolism Hepatic (75%)
Half life 5.6 to 9 hours
Excretion Renal and biliary
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral, IV, topical

Chlortetracycline (trade name Aureomycin®, Lederle) is a tetracycline antibiotic, and was the first tetracycline to be discovered. It was discovered in 1945 by Dr Benjamin Duggar in a soil sample from Sanborn Field at the University of Missouri, yielding an actinomycete, Streptomyces aureofaciens (hence the name Aureomycin). In veterinary medicine, it is commonly used to treat conjunctivitis in cats.[1]

References

Wikipedia content modification information:

  • This page was last modified on 14 May 2008, at 06:34.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Chlortetracycline".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.